- Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model2022 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivoPublication without faculty affiliation